94 related articles for article (PubMed ID: 18719291)
1. Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3/abcc3).
Kitamura Y; Hirouchi M; Kusuhara H; Schuetz JD; Sugiyama Y
J Pharmacol Exp Ther; 2008 Nov; 327(2):465-73. PubMed ID: 18719291
[TBL] [Abstract][Full Text] [Related]
2. Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate.
Vlaming ML; van Esch A; van de Steeg E; Pala Z; Wagenaar E; van Tellingen O; Schinkel AH
Drug Metab Dispos; 2011 Aug; 39(8):1338-44. PubMed ID: 21566011
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of multidrug resistance-associated protein 3 (mrp3/abcc3) in the basolateral efflux of glucuronide conjugates in the mouse small intestine.
Kitamura Y; Kusuhara H; Sugiyama Y
J Pharmacol Exp Ther; 2010 Feb; 332(2):659-66. PubMed ID: 19889793
[TBL] [Abstract][Full Text] [Related]
4. Oral availability of cefadroxil depends on ABCC3 and ABCC4.
de Waart DR; van de Wetering K; Kunne C; Duijst S; Paulusma CC; Oude Elferink RP
Drug Metab Dispos; 2012 Mar; 40(3):515-21. PubMed ID: 22166395
[TBL] [Abstract][Full Text] [Related]
5. Basolateral efflux mediated by multidrug resistance-associated protein 3 (Mrp3/Abcc3) facilitates intestinal absorption of folates in mouse.
Kitamura Y; Kusuhara H; Sugiyama Y
Pharm Res; 2010 Apr; 27(4):665-72. PubMed ID: 20148291
[TBL] [Abstract][Full Text] [Related]
6. Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate.
Vlaming ML; Pala Z; van Esch A; Wagenaar E; van Tellingen O; de Waart DR; Oude Elferink RP; van de Wetering K; Schinkel AH
Clin Cancer Res; 2008 Dec; 14(24):8152-60. PubMed ID: 19088030
[TBL] [Abstract][Full Text] [Related]
7. Impact of basolateral multidrug resistance-associated protein (Mrp) 3 and Mrp4 on the hepatobiliary disposition of fexofenadine in perfused mouse livers.
Tian X; Swift B; Zamek-Gliszczynski MJ; Belinsky MG; Kruh GD; Brouwer KL
Drug Metab Dispos; 2008 May; 36(5):911-5. PubMed ID: 18276836
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- mice.
Zamek-Gliszczynski MJ; Nezasa K; Tian X; Bridges AS; Lee K; Belinsky MG; Kruh GD; Brouwer KL
J Pharmacol Exp Ther; 2006 Dec; 319(3):1485-91. PubMed ID: 16988054
[TBL] [Abstract][Full Text] [Related]
9. Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo.
Vlaming ML; van Esch A; Pala Z; Wagenaar E; van de Wetering K; van Tellingen O; Schinkel AH
Mol Cancer Ther; 2009 Dec; 8(12):3350-9. PubMed ID: 19996279
[TBL] [Abstract][Full Text] [Related]
10. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system.
Chen ZS; Lee K; Walther S; Raftogianis RB; Kuwano M; Zeng H; Kruh GD
Cancer Res; 2002 Jun; 62(11):3144-50. PubMed ID: 12036927
[TBL] [Abstract][Full Text] [Related]
11. Altered hepatobiliary disposition of 5 (and 6)-carboxy-2',7'-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice.
Nezasa K; Tian X; Zamek-Gliszczynski MJ; Patel NJ; Raub TJ; Brouwer KL
Drug Metab Dispos; 2006 Apr; 34(4):718-23. PubMed ID: 16434545
[TBL] [Abstract][Full Text] [Related]
12. Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport.
El-Sheikh AA; van den Heuvel JJ; Koenderink JB; Russel FG
J Pharmacol Exp Ther; 2007 Jan; 320(1):229-35. PubMed ID: 17005917
[TBL] [Abstract][Full Text] [Related]
13. Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney.
Ci L; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
Mol Pharmacol; 2007 Jun; 71(6):1591-7. PubMed ID: 17344354
[TBL] [Abstract][Full Text] [Related]
14. Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice.
Vlaming ML; Mohrmann K; Wagenaar E; de Waart DR; Elferink RP; Lagas JS; van Tellingen O; Vainchtein LD; Rosing H; Beijnen JH; Schellens JH; Schinkel AH
J Pharmacol Exp Ther; 2006 Jul; 318(1):319-27. PubMed ID: 16611851
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione.
Bai J; Lai L; Yeo HC; Goh BC; Tan TM
Int J Biochem Cell Biol; 2004 Feb; 36(2):247-57. PubMed ID: 14643890
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier.
Kanamitsu K; Kusuhara H; Schuetz JD; Takeuchi K; Sugiyama Y
J Pharm Sci; 2017 Sep; 106(9):2566-2575. PubMed ID: 28456721
[TBL] [Abstract][Full Text] [Related]
17. Efflux mechanism of taurocholate across the rat intestinal basolateral membrane.
Sakamoto S; Suzuki H; Kusuhara H; Sugiyama Y
Mol Pharm; 2006; 3(3):275-81. PubMed ID: 16749859
[TBL] [Abstract][Full Text] [Related]
18. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.
Imaoka T; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y
Mol Pharmacol; 2007 Feb; 71(2):619-27. PubMed ID: 17110501
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models.
Wang Z; Zhou Q; Kruh GD; Gallo JM
Drug Metab Dispos; 2011 Nov; 39(11):2155-61. PubMed ID: 21841039
[TBL] [Abstract][Full Text] [Related]
20. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4).
Ose A; Ito M; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Hosokawa M; Schuetz JD; Sugiyama Y
Drug Metab Dispos; 2009 Feb; 37(2):315-21. PubMed ID: 19029202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
